Skip to main content

Advertisement

SpringerLink
Log in

Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L-tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat

  • Original article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Introduction

The positron emission tomography (PET) tracers 18F-fluoro-ethyl-L-tyrosine (FET), 18F-fluorocholine (N,N-dimethyl-N-[18F]fluoromethyl-2-hydroxyethylammonium (FCH]) and 18F-fluoro-2-deoxyglucose (FDG) are used in the diagnosis of brain tumours. The aim of this study was threefold: (a) to assess the uptake of the different tracers in the F98 rat glioma, (b) to evaluate the impact of blood-brain barrier (BBB) disruption and microvessel density (MVD) on tracer uptake and (c) to compare the uptake in the tumours to that in the radiation injuries (induced by proton irradiation of healthy rats) of our previous study.

Methods

F98 gliomas were induced in 26 rats. The uptake of FET, FCH and FDG was measured using autoradiography and correlated with histology, disruption of the BBB and MVD.

Results

The mean FET, FCH and FDG standardised uptake values (SUVs) in the tumour and the contralateral normal cortex (in parentheses) were 4.19±0.86 (1.32±0.26), 2.98±0.58 (0.51±0.11) and 11.02±3.84 (4.76±1.77) respectively. MVD was significantly correlated only with FCH uptake. There was a trend towards a negative correlation between the degree of BBB disruption and FCH uptake and a trend towards a positive correlation with FET uptake. The ratio of the uptake in tumours to that in the radiation injuries was 1.97 (FCH), 2.71 (FET) and 2.37 (FDG).

Conclusion

MVD displayed a significant effect only on FCH uptake. The degree of BBB disruption seems to affect the accumulation of FET and FCH, but not FDG. Mean tumour uptake for all tracers was significantly higher than the accumulation in radiation injuries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, et al. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 1982;32:1323–1329

    PubMed  Google Scholar 

  2. Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 1998;19:407–413

    PubMed  CAS  Google Scholar 

  3. Ohtani T, Kurihara H, Ishiuchi S, Saito N, Oriuchi N, Inoue T, et al. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med 2001;28:1664–1670

    Article  PubMed  CAS  Google Scholar 

  4. Kaim AH, Weber B, Kurrer M, Gottschalk J, von Schulthess GK, Buck A. Autoradiographic quantification of 18F-FDG uptake in experimental soft tissue abscesses in rats. Radiology 2002;223:446–451

    Article  PubMed  Google Scholar 

  5. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972–1980

    PubMed  CAS  Google Scholar 

  6. Hara T, Kondo T, Kosaka N. Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg 2003; 99:474–479

    PubMed  Google Scholar 

  7. Hara T. 11C-choline and 2-deoxy-2-[18F]fluoro-D-glucose in tumor imaging with positron emission tomography. Mol Imaging Biol 2002;4:267–273

    Article  PubMed  Google Scholar 

  8. Weber WA, Wester HJ, Grosu AL, Herz M, Dzewas B, Feldmann HJ, et al. O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 2000;27:542–549

    Article  PubMed  CAS  Google Scholar 

  9. Kaim AH, Weber B, Kurrer MO, Westera G, Schweitzer A, Gottschalk J, et al. 18F-FDG and 18F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging 2002;29:648–654

    Article  PubMed  CAS  Google Scholar 

  10. Wyss MT, Weber B, Honer M, Spath N, Ametamey SM, Westera G, et al. 18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET. Eur J Nucl Med Mol Imaging 2003;20:20

    Google Scholar 

  11. Rau FC, Weber WA, Wester HJ, Herz M, Becker I, Kruger A,et al. O-(2-[18F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging 2002;29:1039–1046

    Article  PubMed  CAS  Google Scholar 

  12. Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 1999;40:205–212

    PubMed  CAS  Google Scholar 

  13. Heiss P, Mayer S, Herz M, Wester HJ, Schwaiger M, Senekowitsch-Schmidtke R. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med 1999;40:1367–1373

    PubMed  CAS  Google Scholar 

  14. Langen KJ, Jarosch M, Muhlensiepen H, Hamacher K, Broer S, Jansen P, et al. Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. Nucl Med Biol 2003;30:501–508

    Article  PubMed  CAS  Google Scholar 

  15. Baum RP, Calcagni M, Dimitrakopoulou-Strauss A, Strauss LG. Pharmakokinetic analysis of O-2-[18F] fluorethyl-L-tyrosin (18F-FET) by dynamic PET in the differential diagnosis of malignant gliomas. J Nucl Med 2003; 44(Suppl):63P

    Google Scholar 

  16. Popperl G, Gotz C, Rachinger W, Gildehaus FJ, Tonn JC, Tatsch K. Value of O-(2-[18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging 2004;31:1464–1470

    Article  PubMed  CAS  Google Scholar 

  17. Weckesser M, Langen KJ, Rickert CH, Kloska S, Straeter R, Hamacher K, et al. O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging 2005;32:422–429

    Article  PubMed  CAS  Google Scholar 

  18. Floeth FW, Pauleit D, Wittsack HJ, Langen KJ, Reifenberger G, Hamacher K, et al Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. J Neurosurg 2005;102:318–327

    Article  PubMed  Google Scholar 

  19. Kracht LW, Friese M, Herholz K, Schroeder R, Bauer B, Jacobs A, et al. Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 2003;30:868–873

    Article  PubMed  CAS  Google Scholar 

  20. Hernandez-Alcoceba R, Saniger L, Campos J, Nunez MC, Khaless F, Gallo MA, et al. Choline kinase inhibitors as a novel approach for antiproliferative drug design. Oncogene 1997;15:2289–2301

    Article  PubMed  CAS  Google Scholar 

  21. Haeffner EW. Studies on choline permeation through the plasma membrane and its incorporation into phosphatidyl choline of Ehrlich-Lettre-ascites tumor cells in vitro. Eur J Biochem 1975;51:219–228

    Article  PubMed  CAS  Google Scholar 

  22. Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res 1996;16:1375–1380

    PubMed  CAS  Google Scholar 

  23. Yoshimoto M, Waki A, Obata A, Furukawa T, Yonekura Y, Fujibayashi Y. Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate. Nucl Med Biol 2004;31:859–865

    Article  PubMed  CAS  Google Scholar 

  24. Henriksen G, Herz M, Hauser A, Schwaiger M, Wester HJ. Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F]fluorocholine ([18F]dOC). Nucl Med Biol 2004;31:851–858

    Article  PubMed  CAS  Google Scholar 

  25. Hara T, Inagaki K, Kosaka N, Morita T Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. J Nucl Med 2000;41:1507–1513

    PubMed  CAS  Google Scholar 

  26. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998;39:990–995

    PubMed  CAS  Google Scholar 

  27. Hara T, Kosaka N, Shinoura N, Kondo T PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med 1997;38:842–847

    PubMed  CAS  Google Scholar 

  28. Kobori O, Kirihara Y, Kosaka N, Hara T. Positron emission tomography of esophageal carcinoma using 11C-choline and 18F-fluorodeoxyglucose: a novel method of preoperative lymph node staging. Cancer 1999;86:1638–1648

    Article  PubMed  CAS  Google Scholar 

  29. Shinoura N, Nishijima M, Hara T, Haisa T, Yamamoto H, Fujii K, et al. Brain tumors: detection with C-11 choline PET. Radiology 1997;202:497–503

    PubMed  CAS  Google Scholar 

  30. DeGrado TR, Baldwin SW, Wang S, Orr MD, Liao RP, Friedman HS, et al. Synthesis and evaluation of 18F-labeled choline analogs as oncologic PET tracers. J Nucl Med 2001;42:1805–1814

    PubMed  CAS  Google Scholar 

  31. Spaeth N, Wyss MT, Weber B, Scheidegger S, Lutz A, Verwey J, et al. Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. J Nucl Med 2004;45:1931–1938

    PubMed  CAS  Google Scholar 

  32. Ambar BB, Frei K, Malipiero U, Morelli AE, Castro MG, Lowenstein PR, et al. Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand. Hum Gene Ther 1999;10:1641–1648

    Article  PubMed  CAS  Google Scholar 

  33. DeGrado TR, Coleman RE, Wang S, Baldwin SW, Orr MD, Robertson CN, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res 2001;61:110–117

    PubMed  CAS  Google Scholar 

  34. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980;238:E69–E82

    PubMed  CAS  Google Scholar 

  35. Mikolajczyk K, Szabatin M, Rudnicki P, Grodzki M, Burger C. A JAVA environment for medical image data analysis: initial application for brain PET quantitation. Med Inform (Lond) 1998;23:207–214

    CAS  Google Scholar 

  36. Saria A, Lundberg JM. Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods 1983;8:41–49

    Article  PubMed  CAS  Google Scholar 

  37. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med 1991;324:1–8

    Article  PubMed  CAS  Google Scholar 

  38. Barth RF. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 1998;36:91–102

    Article  PubMed  CAS  Google Scholar 

  39. Hustinx R, Smith RJ, Benard F, Bhatnagar A, Alavi A. Can the standardized uptake value characterize primary brain tumors on FDG-PET? Eur J Nucl Med 1999;26:1501–1509

    Article  PubMed  CAS  Google Scholar 

  40. Pauleit D, Stoffels G, Schaden W, Hamacher K, Bauer D, Tellmann L, et al. PET with O-(2-18F-fluoroethyl)-L-tyrosine in peripheral tumors: first clinical results. J Nucl Med 2005; 46:411–416

    PubMed  CAS  Google Scholar 

  41. Shinoura N, Nishijima M, Hara T, Haisa T, Yamamoto H, Fujii K, et al. Brain tumors: detection with C-11 choline PET. Radiology 1997;202:497–503

    PubMed  CAS  Google Scholar 

  42. Allen DD, Smith QR. Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique. J Neurochem 2001;76:1032–1041

    Article  PubMed  CAS  Google Scholar 

  43. de Molina AR, Banez-Coronel M, Gutierrez R, Rodriguez-Gonzalez A, Olmeda D, Megias D, et al. Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression. Cancer Res 2004;64:6732–6739

    Article  Google Scholar 

  44. Aronen HJ, Pardo FS, Kennedy DN, Belliveau JW, Packard SD, Hsu DW, et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000;6:2189–2200

    PubMed  CAS  Google Scholar 

  45. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996;77:362–372

    Article  PubMed  CAS  Google Scholar 

  46. Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 1998;39:778–785

    PubMed  CAS  Google Scholar 

  47. Padma MV, Said S, Jacobs M, Hwang DR, Dunigan K, Satter M, et al. Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol 2003;64:227–237

    Article  PubMed  CAS  Google Scholar 

  48. Cheon GJ, Ahn SH, Cho YS, Kwack HS, Lee CH, Choi CW,et al. Correlation of 18F-FET uptake and histologic grades of primary brain tumors. J Nucl Med 2003;44 Suppl:367P

    Google Scholar 

  49. Pauleit D, Floeth F, Hamacher K, Riemenschneider MJ, Reifenberger G, Muller HW, et al. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 2005;128:678–687

    Article  PubMed  Google Scholar 

  50. Pauleit D, Floeth F, Tellmann L, Hamacher K, Hautzel H, Muller HW, et al. Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors. J Nucl Med 2004;45:374–381

    PubMed  CAS  Google Scholar 

  51. Tian M, Zhang H, Higuchi T, Oriuchi N, Endo K. Oncological diagnosis using 11C-choline-positron emission tomography in comparison with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography. Mol Imaging Biol 2004;6:172–179

    Article  PubMed  Google Scholar 

  52. Tian M, Zhang H, Oriuchi N, Higuchi T, Endo K. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur J Nucl Med Mol Imaging 2004;31:1064–1072

    PubMed  CAS  Google Scholar 

  53. Utriainen M, Komu M, Vuorinen V, Lehikoinen P, Sonninen P, Kurki T, et al. Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS. J Neurooncol 2003;62:329–338

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the Sassela-Stiftung, the Olga Mayenfisch-Stiftung and the Huggenberger-Bischof-Stiftung in Zurich. The authors thank Gustav K. von Schulthess and Dominik Weishaupt for valuable discussions, as well as Tibor Cservenyak and Rolf Hesselmann for production of the studied tracers. Valerie Treyer was supported by the Swiss National Science Foundation.

Author information

Authors and Affiliations

  1. PET Center, Division of Nuclear Medicine, University Hospital, Rämistrasse 100, 8091, Zürich, Switzerland

    Nicolas Spaeth, Matthias T. Wyss, Valerie Treyer, Bruno Weber & Alfred Buck

  2. Center for Radiopharmaceutical Science of ETH, PSI and USZ, Paul Scherrer Institute, Villigen und University Hospital, Zurich, Zurich, Switzerland

    Matthias T. Wyss & Gerrit Westera

  3. Department of Pathology, University Hospital, Zurich, Zurich, Switzerland

    Jens Pahnke

  4. Section of Clinical Immunology, University Hospital, Zurich, Zurich, Switzerland

    Gregoire Biollaz

  5. Institute of Diagnostic Radiology, University Hospital, Zurich, Zurich, Switzerland

    Amelie Lutz & Kerstin Goepfert

Authors
  1. Nicolas Spaeth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthias T. Wyss
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jens Pahnke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gregoire Biollaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Amelie Lutz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kerstin Goepfert
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gerrit Westera
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Valerie Treyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bruno Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Alfred Buck
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alfred Buck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spaeth, N., Wyss, M.T., Pahnke, J. et al. Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L-tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat. Eur J Nucl Med Mol Imaging 33, 673–682 (2006). https://doi.org/10.1007/s00259-005-0045-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-005-0045-7

Keywords

Search

Navigation